Specialized Pharmaceutical Manufacturing Capabilities: Maneesh Pharmaceuticals Ltd. offers specialized facilities dedicated to a wide range of therapeutic products including Oral Solids, Betalactum, OTC Range, Derma Range, Soft Gelatin Capsules, Effervescents, Liquids, Ointments, Oral Contraceptives Pills and Hormones. These capabilities position Maneesh Pharmaceuticals Ltd. strongly among leading pharmaceutical manufacturing companies, enabling diverse product development and large-scale production across multiple dosage forms.
Quality-Driven Pharmaceutical Manufacturing: Our pharmaceutical manufacturing facilities adhere to the highest standards of quality and are compliant with stringent regulatory standards that meet our customer’s high expectations and help us achieve high customer satisfaction. This strong quality framework supports reliable pharmaceutical third party manufacturing, pharmaceutical contract manufacturing, ensuring consistent product performance, regulatory compliance, and long-term trust with global partners.
Pharmaceutical Manufacturing Excellence: Maneesh Pharmaceuticals Ltd. has two USFDA approved manufacturing facilities as well as MHRA, UK and WHO, Geneva approvals for solids manufacturing. This robust regulatory foundation strengthens our capabilities in pharmaceutical contract manufacturing, enabling us to serve regulated markets with confidence and deliver products that meet international quality benchmarks.
Innovation in Safety & Authentication: We have also pioneered path breaking initiatives such as hologram and bar coding technologies for checking medicine authenticity and ensuring consumer safety. These innovations reinforce product integrity, strengthen supply chain transparency, and enhance patient trust by ensuring secure and traceable pharmaceutical products across all markets.
Our manufacturing facilities across India include:
Plot No. 40, Ancillary Industrial Plots,
Govandi, Mumbai-400043. INDIA.
| Galenical Form | Capacity/Year (Per shift a day) | Certifications |
|---|---|---|
| Tablets | Uncoated - 400 million Sugar Coated - 100 million Film Coated - 200 million |
WHO, GMP |
| Capsules | 80 million | |
| Lotions Creams Ointments Syrups |
Cosmetics - 15 million bottles | |
| Powder for susp. | 3 million bottles | |
| Injections | 12 million ampoules | |
| Sterile Powder for injections | 8.6 million vials |
Plot D 16/7, TTC Industrial Area, Turbhe, Navi Mumbai 400703, India
| Galenical Form | Capacity/Year (Per shift a day) | Certifications |
|---|---|---|
| Tablets | 50 million | WHO, GMP ANVISA, Brazil MCC, South Africa AGES, Austria |
| Capsules | 100 million | |
| Dry Syrups | 3.5 million bottles | |
| Dry powder injection single dose | 30 million | |
| Water for injection | 30 million |
Khasra No. 337-340, Village Balyana, Pargana Doon, Barotiwala, Tehsil Kasouli, Dist. Solan, Himachal Pradesh, India
| Galenical Form | Capacity/Year (Per shift a day) | Certifications |
|---|---|---|
| General Block - | ||
| Tablets | 1500 million | WHO, GMP |
| Capsules | 300 million | |
| Powders | 600 kg. | |
| Effervescent tablets | 150 million | |
| Cephalosporin Block - | ||
| Tablets | 300 million | |
| Capsules | 300 million | |
| Dry Syrups | 7.5 million kg | |
| Injections | 15 million |
Our manufacturing facilities adhere to the highest standards of quality and are compliant with stringent regulatory standards that meet our customer's expectations and help us achieve high customer satisfaction.
The company has two USFDA, MHRA UK and WHO Geneva approvals for oral solids manufacturing. We have also pioneered path breaking initiatives such as hologram and bar coding technologies for maintaining medicine authenticity and ensuring consumer safety.